Clinical Trial Detail

NCT ID NCT01449370
Title Dose Escalation Study of MLN1117 in Subjects With Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Millennium Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

Therapies

MLN1117

Age Groups: adult senior

No variant requirements are available.